Cardiac Leads Market Size, Share, Trends & Analysis | Global | 2019-2025 | MedCore | Segmented by: Type (Pacing Lead, Defibrillation Lead & LV Lead)
- Year: 2019
- Scope: 10 Years
- Region: Global
- Type: MedCore
The global cardiac leads market size is expected to reach over $2,197 million by 2025, with the left ventricular (LV) lead market segment showing the highest growth.
The majority of the global cardiac leads market share was controlled by Medtronic, Abbott, and Boston Scientific. Overall, this global market research includes an analysis ofcardiac lead manufacturing companies spawning across more than 70 countries in the world.
Cardiac Leads Market Data Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Cardiac Rhythm Management Procedure Volumes
- Market Drivers & Limiters
- Market Forecasts Until 2026, and Historical Data to 2016
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
Cardiac Rhythm Management Procedure Volumes
Through this study on the global cardiac leads market, iData Research has performed an analysis on cardiac rhythm management procedure volumes in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range and across 70 countries.
Cardiac Leads Market Insights
The largest market for cardiac leads was the North American region. Within this region, LV leads remained the largest segment of the total cardiac leads market. The market for cardiac leads included units sold in conjunction with CRM generators and as standalone replacements. Replacements represented just a small fraction of total sales, as lead extraction is a relatively dangerous procedure for the patient.
Overall, the global market size for cardiac leads is expected to grow over the forecast period at 2.9% reaching over $2,197 million in 2025.
Cardiac Leads Market Share Insights
The global cardiac leads market was controlled by three key competitors – Medtronic, Abbott, and Boston Scientific.
Medtronic was the leader of the cardiac lead market. The company gained market share as one of its main competitors, Abbott, experienced a massive recall of its Riata® defibrillation lead line, which also prompted concerns regarding the Durata® product line.
Abbott was the second-leading competitor in the cardiac lead market. The company’s primary lead brands are the Riata® ST and Durata®. Following the 2011/2012 FDA Class I recall of the Riata® product line, Abbott has taken a loss in market share and confidence in its product has dropped dramatically.
Boston Scientific was the third-leading competitor in the cardiac lead market. In addition to the Endotak Reliance™ leads manufactured by its Guidant subsidiary, Boston sold leads manufactured by Biotronik. As Boston Scientific’s market share in the CRM market rose, so did its share of the cardiac lead market.
Research Regional Coverage
Throughout this research series, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Market Segmentation Summary
Contact Us For Additional Information
For full segmentation and any questions regarding research coverage, please contact us or send a request by pressing one of the buttons on the right.
- Boston Scientific
- And More
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.